EANS-News: Epigenomics AG: Clinical Study Shows Lead Biomarker for Lung Cancer also works in Blood
August 25th, 2009
Biomarker mSHOX2 could accelerate diagnostic work-up of patients with suspected lung cancer …In this study the amount of methylated DNA of the SHOX2 gene (mSHOX2) was successfully analyzed in blood plasma samples from 188 patients with confirmed lung cancer of all stages and 155 control patients consisting of individuals with benign lung disease, healthy subjects and smokers.